Vaccination with staphylococcal protein A protects mice against systemic complications of skin infection recurrences

Andrea Paola Mandelli,Greta Magri,Marco Tortoli,Stefania Torricelli,Donatello Laera,Fabio Bagnoli,Oretta Finco,Giuliano Bensi,Michela Brazzoli,Emiliano Chiarot
DOI: https://doi.org/10.3389/fimmu.2024.1355764
IF: 7.3
2024-03-11
Frontiers in Immunology
Abstract:Skin and soft tissue infections (SSTIs) are the most common diseases caused by Staphylococcus aureus ( S. aureus ), which can progress to threatening conditions due to recurrences and systemic complications. Staphylococcal protein A (SpA) is an immunomodulator antigen of S. aureus , which allows bacterial evasion from the immune system by interfering with different types of immune responses to pathogen antigens. Immunization with SpA could potentially unmask the pathogen to the immune system, leading to the production of antibodies that can protect from a second encounter with S. aureus , as it occurs in skin infection recurrences. Here, we describe a study in which mice are immunized with a mutated form of SpA mixed with the Adjuvant System 01 (SpA mut /AS01) before a primary S. aureus skin infection. Although mice are not protected from the infection under these conditions, they are able to mount a broader pathogen-specific functional immune response that results in protection against systemic dissemination of bacteria following an S. aureus second infection (recurrence). We show that this "hidden effect" of SpA can be partially explained by higher functionality of induced anti-SpA antibodies, which promotes better phagocytic activity. Moreover, a broader and stronger humoral response is elicited against several S. aureus antigens that during an infection are masked by SpA activity, which could prevent S. aureus spreading from the skin through the blood.
immunology
What problem does this paper attempt to address?